Mapping the Institutional Healthcare Payer Mix for Total Hip and Knee Arthroplasty: Insight into a Large Practice.

IF 3.4 2区 医学 Q1 ORTHOPEDICS
Nihir Parikh, Alam Lam, William DiCiurcio, Nisha Cherian Matthew, Bryan Wellens, Chad A Krueger
{"title":"Mapping the Institutional Healthcare Payer Mix for Total Hip and Knee Arthroplasty: Insight into a Large Practice.","authors":"Nihir Parikh, Alam Lam, William DiCiurcio, Nisha Cherian Matthew, Bryan Wellens, Chad A Krueger","doi":"10.1016/j.arth.2024.10.117","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>As the demand for total hip (THA) and knee arthroplasty (TKA) continues to grow exponentially, the economic burden on practices and healthcare payers simultaneously increases. Medicare accounts for over 60% of total joint arthroplasty (TJA) cases nationwide, and the reimbursements are worsening despite alternative payment models. Trending the active payers at an institution provides invaluable insight into the financial health of a practice and projects if annual run rates are sustainable.</p><p><strong>Methods: </strong>Insurance and billing claims were analyzed for all THA and TKA cases between January 1, 2019, and December 31, 2022, from various healthcare payers at a single, high-volume institution. The payers included Medicare, Medicare Advantage, and seven commercial payers. The THA and TKA claims are from institutional facilities across two Northeast states - New Jersey (NJ) and Pennsylvania (PA). Volume, charges, and payments from each payer were trended over three years (2019 to 2022).</p><p><strong>Results: </strong>In the years following the COVID-19 pandemic, the number of institutional patients who had Medicare and Medicare Advantage undergoing TJA drastically increased by 29.1% and 37.8%, respectively. As a result, charges spiked by over $20 million for Medicare and nearly $15 million for Medicare Advantage. Despite a higher caseload, the payments received per case decreased by 24.5% for Medicare and 18.7% for Medicare Advantage. Commercial payers grew 20.6% in annual cases, yet payments received per case similarly decreased by 15.0% at the end of 2022.</p><p><strong>Conclusions: </strong>Rising Medicare and Medicare Advantage TJA volume highlights the increase in costs and resource utilization, while diminishing payments underscore the inadequate reimbursement to hospitals and surgeons. Along with stagnant commercial payments, the trend shows concerns about the financial health of THA and TKA institutions that participate in the care of a large number of Medicare patients.</p>","PeriodicalId":51077,"journal":{"name":"Journal of Arthroplasty","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arthroplasty","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.arth.2024.10.117","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: As the demand for total hip (THA) and knee arthroplasty (TKA) continues to grow exponentially, the economic burden on practices and healthcare payers simultaneously increases. Medicare accounts for over 60% of total joint arthroplasty (TJA) cases nationwide, and the reimbursements are worsening despite alternative payment models. Trending the active payers at an institution provides invaluable insight into the financial health of a practice and projects if annual run rates are sustainable.

Methods: Insurance and billing claims were analyzed for all THA and TKA cases between January 1, 2019, and December 31, 2022, from various healthcare payers at a single, high-volume institution. The payers included Medicare, Medicare Advantage, and seven commercial payers. The THA and TKA claims are from institutional facilities across two Northeast states - New Jersey (NJ) and Pennsylvania (PA). Volume, charges, and payments from each payer were trended over three years (2019 to 2022).

Results: In the years following the COVID-19 pandemic, the number of institutional patients who had Medicare and Medicare Advantage undergoing TJA drastically increased by 29.1% and 37.8%, respectively. As a result, charges spiked by over $20 million for Medicare and nearly $15 million for Medicare Advantage. Despite a higher caseload, the payments received per case decreased by 24.5% for Medicare and 18.7% for Medicare Advantage. Commercial payers grew 20.6% in annual cases, yet payments received per case similarly decreased by 15.0% at the end of 2022.

Conclusions: Rising Medicare and Medicare Advantage TJA volume highlights the increase in costs and resource utilization, while diminishing payments underscore the inadequate reimbursement to hospitals and surgeons. Along with stagnant commercial payments, the trend shows concerns about the financial health of THA and TKA institutions that participate in the care of a large number of Medicare patients.

绘制全髋关节和膝关节置换术的机构医疗支付方组合图:大型实践的启示。
导言:随着全髋(THA)和全膝(TKA)关节置换术的需求不断激增,医疗机构和医疗支付方的经济负担也同时加重。在全国范围内,医疗保险占全关节成形术(TJA)病例的 60% 以上,尽管有其他支付模式,但报销情况仍在恶化。对医疗机构的活跃付款人进行趋势分析,可以深入了解医疗机构的财务健康状况,并预测年度运行率是否可持续:方法:我们分析了一家高流量医疗机构在 2019 年 1 月 1 日至 2022 年 12 月 31 日期间所有 THA 和 TKA 病例的保险和账单索赔,这些索赔来自不同的医疗支付方。支付方包括医疗保险、医疗保险优势和七家商业支付方。THA 和 TKA 索赔来自东北部两个州(新泽西州(NJ)和宾夕法尼亚州(PA))的医疗机构。对每个支付方的交易量、费用和支付额进行了三年(2019 年至 2022 年)的趋势分析:结果:在 COVID-19 大流行后的几年里,在医疗保险和医疗保险优势机构接受 TJA 治疗的住院病人数量分别激增了 29.1% 和 37.8%。因此,医疗保险的收费激增了 2000 多万美元,医疗保险优势项目的收费激增了近 1500 万美元。尽管病例量增加了,但每个病例收到的医疗保险付款却减少了 24.5%,医疗保险优势项目减少了 18.7%。商业付款人的年度病例增长了 20.6%,但到 2022 年底,每个病例收到的付款同样减少了 15.0%:结论:Medicare 和 Medicare Advantage TJA 数量的增加凸显了成本和资源利用率的增加,而支付额的减少则强调了对医院和外科医生的补偿不足。这一趋势与停滞不前的商业支付一起,显示出参与护理大量医疗保险患者的 THA 和 TKA 机构的财务健康状况令人担忧。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Arthroplasty
Journal of Arthroplasty 医学-整形外科
CiteScore
7.00
自引率
20.00%
发文量
734
审稿时长
48 days
期刊介绍: The Journal of Arthroplasty brings together the clinical and scientific foundations for joint replacement. This peer-reviewed journal publishes original research and manuscripts of the highest quality from all areas relating to joint replacement or the treatment of its complications, including those dealing with clinical series and experience, prosthetic design, biomechanics, biomaterials, metallurgy, biologic response to arthroplasty materials in vivo and in vitro.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信